IEMbase 0528: LCAT-related fish-eye disease
Scope
| Field | Value |
|---|---|
| IEMbase ID | 528 |
| Nosology | 15.4.22.02 |
| Gene | LCAT |
| External IDs | OMIM:136120; OMIM:606967; ORPHA:79292 |
| Generated mapping | UNMAPPED; low candidate Carnitine_Palmitoyltransferase_II_Deficiency.yaml |
| Candidate DisMech targets | No exact local target |
| Review date | 2026-07-07 |
IEMbase phenotype signal
IEMbase represents partial familial lecithin cholesterol acyl transferase deficiency, with fish-eye disease and FED as alternate labels. The record is autosomal recessive, subtype is marked idiopathic, and no treatments are listed.
Characteristic rows include decreased fibroblast LCAT activity, very low HDL cholesterol, very low apolipoprotein A-I, normal unesterified plasma cholesterol, normal cholesterol esterification rate, normal urinary protein, normal creatinine, and normal to increased serum triglycerides. Clinical characteristic rows include arcus cornealis, corneal clouding, and corneal deposits.
DisMech phenotype coverage
There is no exact local DisMech target for LCAT-related fish-eye disease. The
generated candidate Carnitine_Palmitoyltransferase_II_Deficiency.yaml is a
fatty-acid oxidation disorder and does not model LCAT, cholesterol
esterification, ApoA-I/HDL depletion, or corneal lipid deposition.
This record is related to the earlier IEMbase LCAT deficiency gap, but it is the partial/fish-eye phenotype rather than the classic renal LCAT deficiency phenotype.
Concordance and completeness
Judgement: true local gap; reject the carnitine palmitoyltransferase II candidate.
The IEMbase record should not be collapsed into a generic lipid disorder or a fatty-acid oxidation disease. A future local LCAT entry should decide whether to model classic LCAT deficiency and fish-eye disease as subtypes or closely related spectrum records.
Curation actions
- Keep this record unmapped until an LCAT fish-eye disease or LCAT deficiency spectrum target exists.
- Do not map to
Carnitine_Palmitoyltransferase_II_Deficiency.yaml. - Preserve the partial-LCAT pattern: low LCAT activity, very low HDL/ApoA-I, relatively normal renal/unesterified-cholesterol rows, and corneal clouding/deposit/arcus prompts.